https://www.zacks.com/stock/news/2240143/amn-healthcare-amn-expands-capabilities-of-shiftwise-flex?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2240143
Mar 13, 2024 - AMN Healthcare's (AMN) expansion of the capabilities of ShiftWise Flex is likely to enhance internal resource pool management for the healthcare system.
zc:98026921824207589
0
https://www.zacks.com/stock/news/2240028/pacbio-s-pacb-new-panel-to-aid-its-clinical-research-solution?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2240028
Mar 13, 2024 - PacBio (PACB) announces the PureTarget repeat expansion panel, which is the HiFi long-read sequencing that supports comprehensive analysis of 20 genes associated with neurological diseases.
zc:3995138679419562163
0
https://www.zacks.com/stock/news/2239482/integra-lifesciences-iart-introduces-micromatrix-flex?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2239482
Mar 12, 2024 - Integra LifeSciences' (IART) MicroMatrix Flex has a flexible tip that delivers a flowable version of the Urinary Bladder Matrix (UBM) technology.
zc:2889636430470051462
0
https://www.zacks.com/stock/news/2239363/philips-phg-aids-personal-health-business-with-new-campaign?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2239363
Mar 12, 2024 - Philips (PHG) launches #ShareTheCare brand positioning campaign for Philips Avent, bolstering the Personal Health segment.
zc:5397048864078075533
0
https://www.zacks.com/stock/news/2239362/orthofix-ofix-q4-earnings-beat-estimates-gross-margin-up?cid=CS-ZC-FT-analyst_blog|earnings_article-2239362
Mar 12, 2024 - Orthofix's (OFIX) fourth-quarter earnings and revenues beat their respective consensus estimate. Gross margin expands while the company continues to incur losses at the operating level.
zc:-3730729275862540851
0
https://www.zacks.com/stock/news/2238816/momentum-monday-inflation-data-in-focus-this-week?cid=CS-ZC-FT-video_blog-2238816
Mar 11, 2024 - Want to start the week ahead of the pack? Check out Momentum Mondays
zc:-842648710336779592
0
https://www.zacks.com/stock/news/2238707/thermo-fisher-tmo-unveils-corevitas-clinical-registry-in-gpp?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2238707
Mar 11, 2024 - Thermo Fisher's (TMO) new CorEvitas clinical registry addresses an unmet need for real-world evidence related to the clinical and patient-reported outcomes of patients with GPP.
zc:-7691579945408395418
0
https://www.zacks.com/stock/news/2238699/here-s-why-you-should-retain-teleflex-tfx-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2238699
Mar 11, 2024 - Investors are optimistic about Teleflex (TFX) on robust growth in the Vascular business and strong Urolift prospects.
zc:3572943461378206867
0
https://www.zacks.com/stock/news/2238698/medtronic-s-mdt-minimed-780g-system-study-data-favorable?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2238698
Mar 11, 2024 - Medtronic's (MDT) data from a recent study indicate that the MiniMed 780G system exceeds international targets for TIR and even brings patients closer to euglycemia.
zc:7753606710316964133
0
https://www.zacks.com/stock/news/2237551/here-s-why-you-should-retain-walgreens-boots-wba-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2237551
Mar 07, 2024 - Investors are optimistic about Walgreens Boots (WBA), led by its strategic partnerships and long-term growth model.
zc:-4688381384700326572
0